ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Lexicon Pharmaceuticals (LXRX) Technical (Analysis) Reports Lexicon Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Lexicon Pharmaceuticals (LXRX)

Technical Analysis Report for NASDAQ stock LXRX Lexicon Pharmaceuticals. Dated: 15 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock LXRX Lexicon Pharmaceuticals then click here. or read Experts views on Lexicon Pharmaceuticals or Forecast & share price targets of Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Opened at 1.24 and Closed at: 1.28, which is 2.34% of previous session's close. It moved within a range of 1.23 and 1.29
The session was a Bullish session with an average volume of 1409700, which is 0.75% of previous session's volumes.

    A Golden cross was found 1 days back on short term averages

    Support for tomorrow is 1.26 and resistance for tomorrow is 1.32
    These support and resistance points are valid for the first 5-15 minutes charts

    Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

    Support for tomorrow's hourly charts is 1.24, 1.21 resistance for tomorrow's hourly charts is 1.3, 1.33

    10 Day SMA for Lexicon Pharmaceuticals (LXRX) is 1.19 and stock is trading above these levels. This is a good sign for its short term trend

    20 Day SMA for Lexicon Pharmaceuticals (LXRX) is 1.18 and the stock is trading above these levels. This is a good sign for its mid term trend

    50 Day SMA for Lexicon Pharmaceuticals (LXRX) is 1.31 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

    100 Day SMA is 1.3 and the stock is trading below these levels. This is not a good sign for its long term trend

    200 Day SMA Lexicon Pharmaceuticals is 1.06 and stock is trading above these levels. This is a good sign for its long term trend

    20 DMA of Lexicon Pharmaceuticals is at 1.18 and 200 DMA is at 1.06, while 50 DMA and 100 DMA are at 1.31 and 1.3 respectively

    Lexicon Pharmaceuticals (LXRX) moving average of 20 SMA is at 1.18 and 20 EMA is at 1.23

    Lexicon Pharmaceuticals (LXRX) moving average of 50 SMA is at 1.31 and 50 EMA is at 1.26

    Lexicon Pharmaceuticals (LXRX) moving average of 100 SMA is at 1.3 and 100 EMA is at 1.22

    Lexicon Pharmaceuticals (LXRX) moving average of 200 SMA is at 1.06 and 200 EMA is at 1.08

    Lexicon Pharmaceuticals has performed better than Vanda Pharmaceuticals in short term. Holding Lexicon Pharmaceuticals could be a better choice for now!

    Lexicon Pharmaceuticals has performed better than Repligen Corporation in short term. Holding Lexicon Pharmaceuticals could be a better choice for now!

    Lexicon Pharmaceuticals has performed better than Ovid Therapeutics in short term. Holding Lexicon Pharmaceuticals could be a better choice for now!

    Lexicon Pharmaceuticals has performed better than Nektar Therapeutics in short term. Holding Lexicon Pharmaceuticals could be a better choice for now!

    Lexicon Pharmaceuticals has performed better than Nature S in short term. Holding Lexicon Pharmaceuticals could be a better choice for now!

    Aptevo Therapeutics has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Aptevo Therapeutics, about 764.42% more returns!

    Lexicon Pharmaceuticals has performed better than Assembly Biosciences in short term. Holding Lexicon Pharmaceuticals could be a better choice for now!

    Compugen has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Compugen, about 26.54% more returns!

    Lexicon Pharmaceuticals has performed better than Exelixis Inc in short term. Holding Lexicon Pharmaceuticals could be a better choice for now!

    Lexicon Pharmaceuticals has performed better than Fortress Biotech in short term. Holding Lexicon Pharmaceuticals could be a better choice for now!

    Fortress Biotech has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Fortress Biotech, about 21.92% more returns!

    Lexicon Pharmaceuticals has performed better than Healthcare Services in short term. Holding Lexicon Pharmaceuticals could be a better choice for now!

    Lexicon Pharmaceuticals has performed better than Hologic Inc in short term. Holding Lexicon Pharmaceuticals could be a better choice for now!

    Ironwood Pharmaceuticals has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Ironwood Pharmaceuticals, about 21.84% more returns!

    Lexicon Pharmaceuticals Technical analysis of indicators

    Price action analysis of Lexicon Pharmaceuticals (LXRX) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

    ADX buy sell signal for Lexicon Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

    MACD generated a BUY signal for Lexicon Pharmaceuticals in short term but the buy signal is initial and weak.

    MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

    Lexicon Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.

    Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

    CCI has generated a buy signal for Lexicon Pharmaceuticals in short term and BUY signal is strong.

    RSI is generating a SELL signal in short term and selling is picking up momentum.

    MRSI is in negative zone. This is the SELL zone

    Although the stock is in the SELL zone, but selling might be slowing down

    Stock of Lexicon Pharmaceuticals is picking up selling momentum according to indicator.

    Volume based indicators are showing selling momentum.

    Volume Weighted Averaged Price (VWAP) for short term is 1.19 and Lexicon Pharmaceuticals LXRX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

    People seem to be coming out and selling the Lexicon Pharmaceuticals LXRX stock. Volume based technical analysis of Lexicon Pharmaceuticals LXRX stock is negative.

    Lexicon Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

    Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

    Tomorrow's Predictions

    You should also read Tomorrow's Movement Predictions for NASDAQ stock LXRX Lexicon Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

    And LXRX Experts View which covers a lot of information including buying and selling signals

    LXRX future forecast & share price targets

    You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Lexicon Pharmaceuticals or View Candle Stick Charts here

    Chart Lexicon Pharmaceuticals (LXRX)  Technical (Analysis) Reports Lexicon Pharmaceuticals [

    Videos related to: Lexicon Pharmaceuticals (LXRX) Technical (Analysis) Reports Lexicon Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

    Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

    Hindi Video Most Important Stock Market Video. No Success Without This Formula

    Lexicon Pharmaceuticals (LXRX)  Technical (Analysis) Reports Lexicon Pharmaceuticals [

     

    Back to top